JPRN-UMIN000045833Recruiting未知
The clinical trial to verify accuracy for measuring respiratory and heart rates and respiratory events by ultra-wideband (UWB) radar - The clinical trial by ultra-wideband radar
ihon University of Medicine0 sites80 target enrollmentStarted: October 26, 2021Last updated:
Trial Snapshot
- Phase
- 未知
- Status
- Recruiting
- Sponsor
- Enrollment
- 80
Study Overview
Brief Summary
No summary available.
Study Design
- Study Type
- Interventional
Eligibility Criteria
- Ages
- 20years-old to 80years-old (—)
- Sex
- All
Inclusion Criteria
- Not provided
Exclusion Criteria
- •1.Patients who were already diagnosed as sleep apnea syndrome and treated. 2. Physically disabled patients 3.Patients who refuse to participate in this trial 4.Patients who are judged as inappropriate candidates by the doctor.
Investigators
Similar Trials
Not yet recruiting
Not Applicable
Seven Day Study of a Combined Insulin Cannula and Glucose Sensor Delivering Basal and Bolus Insulin in Persons with Type 1 DiabetesMetabolic and Endocrine - Diabetestype 1 diabetesACTRN12619001295134St Vincent's Hospital Melbourne12
Completed
Not Applicable
Clinical investigation to validate the accuracy of ThermoFlash®Pro used by health care professionals under real-life conditionsAs this is a medical device, we work according to ISO 80601-2-56 (2017). For thermometers, independent of diseaseDRKS00032633BIOSYNEX116
Not yet recruiting
Unknown
A clinical trial to verify the accuracy of Seers Technology’s pulse oximeter (mobiCARE +Pulse, MP100W) in healthy volunteersKCT0008376Asan Medical Center12
Recruiting
Not Applicable
A clinical trial designed to verify the effectiveness of a low-level medical laser apparatus TINI” in improving tinnitus symptoms of chronic high-frequency tinnitus patientsDiseases of the ear and mastoid processKCT0006636WONTECH56
Active, not recruiting
Not Applicable
A Phase II Clinical Trial to Evaluate the Accuracy of FDG-/FLT- PET for Early Prediction of Non-Progression in Patients with Advanced Non Small Cell Lung Cancer (NSCLC) treated with Erlotinib and to Associate PET Findings with Molecular Markers - ERLOPETEUCTR2005-005393-73-DEniversity Cologne40